| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | 30-Sep-08 | | Total Revenue | 226,159 | 225,292 | 240,391 | 299,547 | | Cost of Revenue | 73,806 | 79,278 | 83,325 | 88,786 | | | Gross Profit | 152,353 | 146,014 | 157,066 | 210,761 | | | Operating Expenses | | Research Development | 46,562 | 44,752 | 48,361 | 47,366 | | Selling General and Administrative | 93,068 | 89,080 | 101,299 | 106,907 | | Non Recurring | 6,909 | 9,788 |
-
| 4,735 | | Others | 3,827 | 3,815 | 3,868 | 4,327 | | | | Total Operating Expenses | 150,366 | 147,435 |
-
| 163,335 | | | | Operating Income or Loss | 1,987 | (1,421) | 3,538 | 47,426 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 7,323 | | Earnings Before Interest And Taxes | 1,987 | (1,421) | 3,538 | 54,749 | | Interest Expense | 491 | 250 | 1,071 | 7,823 | | Income Before Tax | 1,496 | (1,671) | 2,467 | 46,926 | | Income Tax Expense | (2,292) | (8,846) | (2,192) | 10,422 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,788 | 7,175 | 4,659 | 36,504 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,788 | 7,175 | 4,659 | 36,504 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,788 | $7,175 | $4,659 | $36,504 |
|
0.17% Nasdaq 
Income Statement
